Patents-Review.com
ClassID:

118030 ⎘

C12Y406/01002 - CPC Classification

Classification description:

Phosphorus-oxygen lyases (4.6.1) Guanylate cyclase (4.6.1.2)

Recent Application in this class:
#1
20260055209
2026-02-26

Nanobody Target GCC and Uses in Chimeric Antigen Receptor Cell Therapy

 #2
20260028421
2026-01-29

ANTIGEN-BINDING MOLECULE SPECIFICALLY BINDING TO GUCY2C AND CD3 AND PHARMACEUTICAL USE THEREOF

 #3
20250312429
2025-10-09

ANTI-GUCY2C VACCINES AND VACCINATION

 #4
20250171497
2025-05-29

ULTRA-PURE AGONISTS OF GUANYLATE CYCLASE C, METHOD OF MAKING AND USING SAME

 #5
20250075006
2025-03-06

ANTI-GUCY2C NANO-ANTIBODY AND APPLICATION THEREOF

 #6
20250049881
2025-02-13

FORMULATIONS OF GUANYLATE CYCLSE C AGONISTS AND METHODS OF USE

 #7
20250002936
2025-01-02

RETGC Gene Therapy

 #8
20240407639
2024-12-12

MINIMALLY-INVASIVE MEASUREMENT OF ESOPHAGEAL INFLAMMATION

 #9
20240301386
2024-09-12

Soluble Guanylyl Cyclase (GC1) Mimetic Polypeptides and Methods of Use Thereof

 #10
20240287137
2024-08-29

Ultra-pure agonists of guanylate cyclase C, method of making and using same

 #11
20240050473
2024-02-15

COMPOSITIONS OF GUANYLYL CYCLASE C (GCC) ANTIGEN BINDING AGENTS AND METHODS OF USE THEREOF

 #12
20230340023
2023-10-26

Ultra-pure agonists of guanylate cyclase C, method of making and using same

 #13
20230074145
2023-03-09

Nanobody target GCC and uses in chimeric antigen receptor cell therapy

 #14
20220186260
2022-06-16

RAAV-GUANYLATE CYCLASE COMPOSITIONS AND METHODS FOR TREATING LEBER'S CONGENITAL AMAUROSIS-1 (LCA1)

 #15
20220119449
2022-04-21

ULTRA-PURE AGONISTS OF GUANYLATE CYCLASE C, METHOD OF MAKING AND USING SAME

 #16
20210403508
2021-12-30

Ultra-pure agonists of guanylate cyclase C, method of making and using same

 #17
20210371492
2021-12-02

Anti-GCC antibody and CAR thereof for treating digestive system cancer

 #18
20210205406
2021-07-08

FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE

 #19
20210180069
2021-06-17

STRUCTURE, MANUFACTURING AND USES OF HUMAN-DERIVED CELL-PERMEABLE PEPTIDES CONJUGATED WITH SPECIFIC BIOLOGICALLY ACTIVE CARGO PEPTIDES

 #20
20210145700
2021-05-20

GENETIC PRODUCTS DIFFERENTIALLY EXPRESSED IN TUMORS AND THE USE THEREOF

 #21
20200399315
2020-12-24

Ultra-pure agonists of guanylate cyclase C, method of making and using same

 #22
20200384068
2020-12-10

FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE

 #23
20200352430
2020-11-12

Minimally-invasive measurement of esophageal inflammation

 #24
20200009213
2020-01-09

Specific Increase of Dopamine Synthesis THrough Targeting of the Guanylate Cyclase 2C Receptor in the Treatment of Parkinson's Disease

 #25
20190321439
2019-10-24

FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE

 #26
20190153450
2019-05-23

Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides

 #27
20190002501
2019-01-03

Ultra-pure agonists of guanylate cyclase C, method of making and using same

 #28
20180344143
2018-12-06

Minimally-invasive measurement of esophageal inflammation

 #29
20180207229
2018-07-26

Formulations of guanylate cyclase C agonists and methods of use

 #30
20180100165
2018-04-12

RAAV-GUANYLATE CYCLASE COMPOSITIONS AND METHODS FOR TREATING LEBER'S CONGENITAL AMAUROSIS-1 (LCA1)

 #31
20170081652
2017-03-23

Near-infrared light-activated proteins

 #32
20170071464
2017-03-16

Minimally-invasive measurement of esophageal inflammation

 #33
20160152665
2016-06-02

Compositions and methods of treatment of cancers

 #34
20160145307
2016-05-26

Ultra-pure agonists of guanylate cyclase C, method of making and using same

 #35
20160136293
2016-05-19

Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides

 #36
20150366935
2015-12-24

Formulations of guanylate cyclase C agonists and methods of use

 #37
20150315287
2015-11-05

Antibody to genetic products differentially expressed in tumors and the use thereof

 #38
20140088023
2014-03-27

sGCalphal inhibiting compositions

 #39
20130291132
2013-10-31

ANF-RGC in-gene knock-out animal

 #40
20130210895
2013-08-15

rAAV-guanylate cyclase compositions and methods for treating lebers congenital amaurosis-1 (LCA1)

 #41
20130030041
2013-01-31

Near-infrared light-activated proteins

 #42
20100240965
2010-09-23

Minimally-invasive measurement of esophageal inflammation

 #43
20080166350
2008-07-10

Genetic products differentially expressed in tumors and the use thereof

 #44
20050176043
2005-08-11

Methods of detecting human diseases using a human genomic polynucleotide

 #45
20050048479
2005-03-03

Adenylyl and guanylyl cyclases